296 related articles for article (PubMed ID: 11427624)
1. Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.
Luippold G; Beilharz M; Mühlbauer B
Nephrol Dial Transplant; 2001 Jul; 16(7):1350-6. PubMed ID: 11427624
[TBL] [Abstract][Full Text] [Related]
2. Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats.
Luippold G; Beilharz M; Wehrmann M; Unger L; Gross G; Mühlbauer B
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):420-7. PubMed ID: 15887004
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2-like receptors and amino acid-induced glomerular hyperfiltration in humans.
Luippold G; Schneider S; Stefanescu A; Benöhr P; Mühlbauer B
Br J Clin Pharmacol; 2001 May; 51(5):415-21. PubMed ID: 11421998
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of exogenous dopamine: modulation by renal nerves and dopamine receptor antagonists.
Luippold G; Osswald H; Mühlbauer B
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):445-51. PubMed ID: 9826067
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-dopa decarboxylase inhibitor benserazide on renal function in streptozotocin-diabetic rats.
Pfeil K; Staudacher T; Luippold G
Kidney Blood Press Res; 2006; 29(1):43-7. PubMed ID: 16636577
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
[TBL] [Abstract][Full Text] [Related]
7. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
Jaffa AA; Rust PF; Mayfield RK
Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
[TBL] [Abstract][Full Text] [Related]
8. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats.
Luippold G; Beilharz M; Mühlbauer B
Nephrol Dial Transplant; 2004 Feb; 19(2):342-7. PubMed ID: 14736957
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
10. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
11. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
Komers R; Allen TJ; Cooper ME
Diabetes; 1994 Oct; 43(10):1190-7. PubMed ID: 7926287
[TBL] [Abstract][Full Text] [Related]
12. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2 receptors mediate glomerular hyperfiltration due to amino acids.
Luippold G; Mühlbauer B
J Pharmacol Exp Ther; 1998 Sep; 286(3):1248-52. PubMed ID: 9732385
[TBL] [Abstract][Full Text] [Related]
14. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
[TBL] [Abstract][Full Text] [Related]
15. Insulin induces the correlation between renal blood flow and glomerular filtration rate in diabetes: implications for mechanisms causing hyperfiltration.
Pihl L; Persson P; Fasching A; Hansell P; DiBona GF; Palm F
Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R39-47. PubMed ID: 22461175
[TBL] [Abstract][Full Text] [Related]
16. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
Vallon V; Albinus M; Blach D
J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
[TBL] [Abstract][Full Text] [Related]
17. Effects of C-peptide on renal function at the early stage of experimental diabetes.
Sjöquist M; Huang W; Johansson BL
Kidney Int; 1998 Sep; 54(3):758-64. PubMed ID: 9734600
[TBL] [Abstract][Full Text] [Related]
18. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption.
Nordquist L; Brown R; Fasching A; Persson P; Palm F
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1265-72. PubMed ID: 19741019
[TBL] [Abstract][Full Text] [Related]
19. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Sjöquist M
Kidney Int; 2001 Oct; 60(4):1258-65. PubMed ID: 11576340
[TBL] [Abstract][Full Text] [Related]
20. Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats.
Tucker BJ; Rasch R; Blantz RC
J Clin Invest; 1993 Aug; 92(2):686-94. PubMed ID: 8349807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
